Medicine: Lifesaver Drug

A new drug may improve the odds for successful transplants

The 12,000 organ transplants performed in the U.S. each year are often successful only because the patients take a daily dose of cyclosporine. The drug keeps their immune systems from attacking and rejecting the foreign organs. But it is not perfect. Some 70% of patients getting a new liver, for example, still suffer rejection episodes. And many organ recipients face life- threatening side effects from cyclosporine, including an increased risk of cancer and heart disease.

Now a respected researcher who was one of the first to use cyclosporine may have found a better way to make transplants succeed. Dr. Thomas Starzl...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!